(Q42937122)

English

The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo

scientific article published on 9 July 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 November 2017

The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo (English)

1 reference

Europe PubMed Central

11 November 2017

Francesca Bonifazi

10

1 reference

Europe PubMed Central

11 November 2017

Paolo Corradini

18

1 reference

Europe PubMed Central

11 November 2017

23

1 reference

Europe PubMed Central

11 November 2017

Cristina Boschini

object named as

C Boschini

4

0 references

Armando Santoro

1 reference

ORCID Public Data File 2021

author name string

E Todisco

1

1 reference

Europe PubMed Central

11 November 2017

F Ciceri

2

1 reference

Europe PubMed Central

11 November 2017

E Oldani

3

1 reference

Europe PubMed Central

11 November 2017

C Micò

5

1 reference

Europe PubMed Central

11 November 2017

M T Vanlint

6

1 reference

Europe PubMed Central

11 November 2017

I Donnini

7

1 reference

Europe PubMed Central

11 November 2017

F Patriarca

8

1 reference

Europe PubMed Central

11 November 2017

P E Alessandrino

9

1 reference

Europe PubMed Central

11 November 2017

W Arcese

11

1 reference

Europe PubMed Central

11 November 2017

W Barberi

12

1 reference

Europe PubMed Central

11 November 2017

P Marenco

13

1 reference

Europe PubMed Central

11 November 2017

E Terruzzi

14

1 reference

Europe PubMed Central

11 November 2017

S Cortelazzo

15

1 reference

Europe PubMed Central

11 November 2017

S Santarone

16

1 reference

Europe PubMed Central

11 November 2017

A Proia

17

1 reference

Europe PubMed Central

11 November 2017

E Tagliaferri

19

1 reference

Europe PubMed Central

11 November 2017

S Falcioni

20

1 reference

Europe PubMed Central

11 November 2017

G Irrera

21

1 reference

Europe PubMed Central

11 November 2017

L Dallanegra

22

1 reference

Europe PubMed Central

11 November 2017

A Santoro

24

1 reference

Europe PubMed Central

11 November 2017

A Camboni

25

1 reference

Europe PubMed Central

11 November 2017

N Sacchi

26

1 reference

Europe PubMed Central

11 November 2017

A Bosi

27

1 reference

Europe PubMed Central

11 November 2017

A Bacigalupo

28

1 reference

Europe PubMed Central

11 November 2017

A Rambaldi

29

1 reference

Europe PubMed Central

11 November 2017

publication date

9 July 2013

1 reference

Europe PubMed Central

11 November 2017

1 reference

Europe PubMed Central

11 November 2017

27

1 reference

Europe PubMed Central

11 November 2017

10

1 reference

Europe PubMed Central

11 November 2017

2086-2091

1 reference

Europe PubMed Central

11 November 2017

https://scigraph.springernature.com/pub.10.1038/leu.2013.208

0 references

Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3806246

27 May 2018

Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3806246

27 May 2018

Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3806246

27 May 2018

Defining the intensity of conditioning regimens: working definitions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3806246

27 May 2018

Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3806246

27 May 2018

Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3806246

27 May 2018

Treatment of refractory AML.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3806246

27 May 2018

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3806246

16 August 2018

The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparison

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3806246

16 August 2018

Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3806246

16 August 2018

Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3806246

16 August 2018

Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3806246

16 August 2018

Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23835862

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/LEU.2013.208

1 reference

Europe PubMed Central

11 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

11 November 2017

1 reference

Europe PubMed Central

11 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42937122&oldid=1974067865"